Nuvalent (NUVL) Short Interest Ratio & Short Volume

Short interest is the volume of Nuvalent shares that have been sold short but have not yet been covered or closed out. As of November 15th, investors have sold 6,580,000 shares of NUVL short. 21.02% of Nuvalent's shares are currently sold short. Learn More on Nuvalent's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NUVL shares currently have a short interest ratio of 9.0. Learn More on Nuvalent's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Nuvalent: Simplex Trading LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 21.02% of Nuvalent's floating shares are currently sold short.

Nuvalent currently has issued a total of 62,630,000 shares. Some of Nuvalent's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Nuvalent currently has a public float of 31,300,000 shares.

21.02% of Nuvalent's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Nuvalent: Evotec SE (0.01%), ACADIA Pharmaceuticals Inc. (4.74%), Insmed Incorporated (9.90%), HUTCHMED (China) Limited (0.30%), Madrigal Pharmaceuticals, Inc. (24.30%), Ultragenyx Pharmaceutical Inc. (4.26%), Axsome Therapeutics, Inc. (16.15%), Arrowhead Pharmaceuticals, Inc. (7.80%), Mirati Therapeutics, Inc. (8.68%), Cytokinetics, Incorporated (14.64%),

As of the most recent reporting period, the following stocks had the largest short interest positions: RTX Co. ($7.24 billion), T-Mobile US, Inc. ($4.02 billion), Charter Communications, Inc. ($3.72 billion), Occidental Petroleum Co. ($2.80 billion), Lululemon Athletica Inc. ($2.48 billion), Coinbase Global, Inc. ($2.38 billion), Tractor Supply ($2.35 billion), Rivian Automotive, Inc. ($1.79 billion), Royal Caribbean Cruises Ltd. ($1.73 billion), and Moderna, Inc. ($1.71 billion). View all of the most shorted stocks.

Short selling NUVL is an investing strategy that aims to generate trading profit from Nuvalent as its price is falling. NUVL shares are trading up $0.48 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Nuvalent occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NUVL, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NUVL, twice per month. The most recent reporting period available is November, 15 2023.